Skolkovo Foundation

Skolkovo Foundation

Skolkovo Foundation

Overview
Date Founded

2010

Headquarters

12 Krasnopresnenskaya Embankment,Entrance 9, 24th floor,Moscow, Moskovskaya obl. 123610

Charitable Causes

Philanthropy, Voluntarism, and Grantmaking Foundations

Employees (Worldwide)

251 - 500

Industries

Management Consulting
Hospitals & Patient Services
Other Business & Consulting Services
Consumer Services
Computer Software

Company Description

Skolkovo Foundation is a Russian organization that fosters startups and venture capitals focused on the areas of energy, IT, biomedicine, nuclear, and space. The IT cluster develops strategic directions of information technologies, including search systems and cloud calculations. The biomed cluster supports and develops innovations in the field of biomedical technologies. The energy Efficiency cluster supports innovations and advanced technologies, aimed at the reduction of energy consumption by industrial and residential objects as well as lower energy consumption by communal services and municipal infrastructure facilities. The space technologies cluster handles space projects and the development of telecommunication technologies based on space tourism, satellite navigation systems, and more. The nuclear technology cluster supports the creation of new products for power markets, development of new materials, and designing of complex technological systems. In order to carry out its operations, Skolkovo Foundation manages Skolkovo Innovation Center, Technopark, Skolkovo Institute of Technology (Skoltech), and Skolkovo city. Several companies, including Boeing, Cisco Systems, EADS, GE, Johnson & Johnson, IBM, Intel, Microsoft, Siemens, Nokia, and Samsung have signed R&D partnership agreements with Skolkovo Foundation. Skolkovo Foundation was founded in September 2010 and is based in Moscow, Russia.

Executives & Employees

Chief Executive Officer, Chairman of the Board

Executive Director

Chief Operating Officer

Chief Editor

Chief Editor

Director, Head of Industrial Portfolio Development

Director, Investment Office

PR & Marketing Director

Vice President, International Relations & Communications

Board of Directors

Founder at JC2 Ventures LLC

President & Chief Executive Officer at Oil Co. LUKOIL PJSC

Former Chairman at Bouygues SA

Chief Executive Officer, Chairman of the Board at Skolkovo Foundation

Co-Founder at Almaz Capital Management Ltd.

Executive Director at TMK PAO

Member, Board of Directors at Russian Venture Co. OJSC

PR & Marketing Director at Skolkovo Foundation

Paths to Skolkovo Foundation
Potential Connections via
Relationship Science
You
Skolkovo Foundation
Non-Profit Donations & Grants
Suppliers
Selecta Biosciences, Inc. Biotechnology | Watertown, MA

Selecta Biosciences, Inc. operates as a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. It produces the Synthetic Vaccine Particles (SVP) platform for immune tolerance and immune stimulation. The firm's proprietary pipeline includes SVP-enabled enzyme, oncology and gene therapies. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian in 2007 and is headquartered in Watertown, MA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Skolkovo Foundation. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Skolkovo Foundation's profile does not indicate a business or promotional relationship of any kind between RelSci and Skolkovo Foundation.